We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Eyesight Restored in Blind Mice

By HospiMedica staff writers
Posted on 05 Dec 2006
An innovative surgery has restored sight in blind mice, and offers the promise of a cure for humans suffering from blindness due to common conditions such as macular degeneration and diabetic eye damage. More...


A research team from University College London (UK), Moorfields Eye Hospital (London, UK), and the University of Michigan (Ann Arbor, MI, USA) implanted mice with genetic defects--loss of photoreceptors--with immature retinal cells, similar to stem cells. The retinal cells had been extracted from newborn mice whose eyesight was developing. The transplanted cells developed into fully functioning photoreceptors that successfully connected to nerves leading to the brain. Tests confirmed that the photoreceptors were functioning and that the animals' vision had been restored to about one-fourth of the normal level.

The initial tests involved "rod” cell transplants, cells that control peripheral and night vision. The researchers suggested that transplanting "cone” cells--those that control color and detail--would greatly improve results. Using differentiated cells may be the key to the success of the procedure, according to the research team, since previous attempts to achieve the same result using undifferentiated stem cells have failed. It may also be possible to grow precursor photoreceptor cells using cells similar to stem cells that are found at the margins of the adult retina. Using the patient's own cells would also avoid the possibility of donor cells being rejected by the body. The study was published in the November 8, 2006, edition of Nature.

"Rather than focusing on stem cells, we believed that if we could understand how cells develop and become photoreceptors...our transplantation efforts would meet with greater success,” said co-author Professor Anand Swaroop, Ph.D., of the University of Michigan Medical School. "This technique gives us new insights in repairing damage to the retina and possibly other parts of the central nervous system.”



Related Links:
University College London
Moorfields Eye Hospital
University of Michigan

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.